NCT05938270
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05938270
Title A Study to Investigate the Biological Effects of AZD5305, Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. (ASCERTAIN)
Acronym ASCERTAIN
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | GBR | ESP | CAN | AUS

Facility Status City State Zip Country Details
Research Site Detroit Michigan 48202 United States Details
Research Site Providence Rhode Island 02903 United States Details
Research Site Melbourne VIC 3000 Australia Details
Research Site South Brisbane 4101 Australia Details
Research Site Vancouver British Columbia V5Z 1M9 Canada Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Québec Quebec G1J 1Z4 Canada Details
Research Site Amsterdam 1066CX Netherlands Details
Research Site Nijmegen 6525 GA Netherlands Details
Research Site Barcelona 08036 Spain Details
Research Site Barcelona 8035 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Valencia 46009 Spain Details
Research Site Cambridge CB2 0QQ United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
Research Site Newcastle upon Tyne NE7 7AF United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field